162 related articles for article (PubMed ID: 19342370)
1. SPARC accelerates disease progression in experimental crescentic glomerulonephritis.
Sussman AN; Sun T; Krofft RM; Durvasula RV
Am J Pathol; 2009 May; 174(5):1827-36. PubMed ID: 19342370
[TBL] [Abstract][Full Text] [Related]
2. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F577-84. PubMed ID: 16093428
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.
Dai Y; Chen A; Liu R; Gu L; Sharma S; Cai W; Salem F; Salant DJ; Pippin JW; Shankland SJ; Moeller MJ; Ghyselinck NB; Ding X; Chuang PY; Lee K; He JC
Kidney Int; 2017 Dec; 92(6):1444-1457. PubMed ID: 28756872
[TBL] [Abstract][Full Text] [Related]
4. The role of podocytes dysfunction in chronic glomerulonephritis progression.
Chebotareva NV; Bobkova IN; Lysenko LV
Ter Arkh; 2018 Jun; 90(6):92-97. PubMed ID: 30701911
[TBL] [Abstract][Full Text] [Related]
5. Injured Podocytes Are Sensitized to Angiotensin II-Induced Calcium Signaling.
Binz-Lotter J; Jüngst C; Rinschen MM; Koehler S; Zentis P; Schauss A; Schermer B; Benzing T; Hackl MJ
J Am Soc Nephrol; 2020 Mar; 31(3):532-542. PubMed ID: 31924670
[TBL] [Abstract][Full Text] [Related]
6. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
[TBL] [Abstract][Full Text] [Related]
7. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.
Ding F; Wickman L; Wang SQ; Zhang Y; Wang F; Afshinnia F; Hodgin J; Ding J; Wiggins RC
Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557
[TBL] [Abstract][Full Text] [Related]
8. The expression of podocyte-specific proteins in parietal epithelial cells is regulated by protein degradation.
Guhr SS; Sachs M; Wegner A; Becker JU; Meyer TN; Kietzmann L; Schlossarek S; Carrier L; Braig M; Jat PS; Stahl RA; Meyer-Schwesinger C
Kidney Int; 2013 Sep; 84(3):532-44. PubMed ID: 23615505
[TBL] [Abstract][Full Text] [Related]
9. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis.
Dai Y; Gu L; Yuan W; Yu Q; Ni Z; Ross MJ; Kaufman L; Xiong H; Salant DJ; He JC; Chuang PY
Kidney Int; 2013 Nov; 84(5):950-61. PubMed ID: 23842188
[TBL] [Abstract][Full Text] [Related]
11. Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D.
van Roeyen CR; Eitner F; Boor P; Moeller MJ; Raffetseder U; Hanssen L; Bücher E; Villa L; Banas MC; Hudkins KL; Alpers CE; Ostendorf T; Floege J
Kidney Int; 2011 Dec; 80(12):1292-305. PubMed ID: 21866094
[TBL] [Abstract][Full Text] [Related]
12. The contribution of podocytes to chronic allograft nephropathy.
Pippin J; Kumar V; Stein A; Jablonski P; Shankland SJ; Davis CL
Nephron Exp Nephrol; 2009; 111(1):e1-10. PubMed ID: 19052472
[TBL] [Abstract][Full Text] [Related]
13. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.
Brähler S; Ising C; Hagmann H; Rasmus M; Hoehne M; Kurschat C; Kisner T; Goebel H; Shankland S; Addicks K; Thaiss F; Schermer B; Pasparakis M; Benzing T; Brinkkoetter PT
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1473-85. PubMed ID: 22975019
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.
Hidaka T; Suzuki Y; Yamashita M; Shibata T; Tanaka Y; Horikoshi S; Tomino Y
Am J Pathol; 2008 Mar; 172(3):603-14. PubMed ID: 18245810
[TBL] [Abstract][Full Text] [Related]
16. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
Chen LP; Zhou QL; Peng WS; Wu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
[TBL] [Abstract][Full Text] [Related]
17. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
18. Urinary Markers of Podocyte Dysfunction in Chronic Glomerulonephritis.
Chebotareva N; Bobkova I; Lysenko L; Moiseev S
Adv Exp Med Biol; 2021; 1306():81-99. PubMed ID: 33959907
[TBL] [Abstract][Full Text] [Related]
19. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis.
Dylewski JF; Tonsawan P; Garcia G; Lewis L; Blaine J
PLoS One; 2020; 15(12):e0230401. PubMed ID: 33370294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
